These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13941173)

  • 1. [Study of the therapeutic effects of a butyrophenone (R-1625--Haloperidin--haloperidol) in psychoses].
    PALAIOLOGOS A; SIGALOS I; SPATHARAS G; TERENTIOS E
    Hell Iatr; 1963 May; 32():473-502. PubMed ID: 13941173
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE USE OF A BUTYROPHENONE NEUROLEPTIC (HALOPERIDOL) IN ACUTE AND CHRONIC PSYCHOSES].
    MADALENA JC; FERREIRA LR; BELLO H
    Rev Assoc Med Bras; 1963; 9():375-86. PubMed ID: 14163287
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICO-THERAPEUTIC TRIALS WITH DIPIPERON, A NEW BUTYROPHENONE SERIES DERIVATIVE].
    SCHWARZ H; KRUEGER HJ; JUENEMANN HJ
    Acta Neurol Psychiatr Belg; 1964 Apr; 64():401-12. PubMed ID: 14176013
    [No Abstract]   [Full Text] [Related]  

  • 4. [HUNTINGTON'S CHOREA, TEMPERAMENT DISORDERS OF MANIAC EXPRESSION. BENEFICIAL EFFECTS OF HALOPERIDOL (FLUORO-PHENYL-PIPERIDINE BUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
    NAYRAC P; ARNOTT G; MILBLED G
    Lille Med; 1964 Oct; 9():765-8. PubMed ID: 14210922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials of a new neuroleptic of the butyrophenone group].
    VELLOSO FM; PAPROCKI J
    Hospital (Rio J); 1963 Jun; 63():1427-34. PubMed ID: 13996630
    [No Abstract]   [Full Text] [Related]  

  • 6. [CB-8089 (BENZPERIDOL-FLUORINATED BUTYROPHENONE) IN PSYCHOMOTOR AGITATION STATES AND MENTAL DISORDERS].
    CHATAGON C; CHATAGNON PA
    Presse Med (1893); 1964 Sep; 72():2151-2. PubMed ID: 14186307
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE PLACE OF A NEW BUTYROPHENONE PIPERAZINE (2028 MD) IN THE TREATMENT OF PSYCHOMOTOR AGITATION].
    FAVRE-TISSOT M; ROBERT J
    J Med Lyon; 1964 Oct; 45():1781-91. PubMed ID: 14238006
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind study with two butyrophenone derivatives: bromperidol vs. haloperidol.
    Pöldinger W; Bures E; Haage H
    Int Pharmacopsychiatry; 1977; 12(3):184-92. PubMed ID: 334688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C.B. 8089 (FLUORIZED BUTYROPHENONE) IN STATES OF PSYCHOMOTOR AGITATION AND IN CHARACTER DISORDERS AT ALL AGES (EXCEPT CHILDHOOD)].
    CHATAGNON PA; CHATAGNON C
    Ann Med Psychol (Paris); 1964 May; 122():809-16. PubMed ID: 14150706
    [No Abstract]   [Full Text] [Related]  

  • 10. PILOT STUDY OF INTRAMUSCULAR HALOANISONE AND HALOPERIDOL IN DISTURBED PSYCHOTICS.
    HEKIMIAN LJ; FRIEDHOFF AJ
    J New Drugs; 1964; 4(5):264-7. PubMed ID: 14218620
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT OF CHRONIC PSYCHOSES WITH HALOPERIDOL (R 1625)].
    LUNA NE
    Sem Med; 1964 Apr; 124():973-5. PubMed ID: 14183757
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 13. The therapeutic profile of haloperidol. A preliminary study of a butyrophenone derivative in in-patients and out-patients.
    PALEY HM; HANKOFF LD; KAWI AA; MENDELSOHN FS
    J Neuropsychiatr; 1962; 4():39-42. PubMed ID: 13941197
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with a new butyrophenone derivative (Buronil).
    Vangtorp A; Simmelsgaard H; Mellegaard M
    Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the treatment with Haloperidol (fluoro-piperidino-butyrophenone) in child psychiatry].
    HABERLANDT WF
    Med Welt; 1963 Jan; 4():210-2. PubMed ID: 13951642
    [No Abstract]   [Full Text] [Related]  

  • 16. THE BUTYROPHENONES IN THE TREATMENT OF THE PSYCHOTIC PATIENT.
    KURLAND AA; FERRO-DIAZ P; MCCUSKER K
    Compr Psychiatry; 1964 Jun; 5():179-90. PubMed ID: 14156874
    [No Abstract]   [Full Text] [Related]  

  • 17. [TREATMENT OF ACUTE COMPLICATIONS OF CHRONIC ALCOHOLISM WITH R-1625 (HALOPERIDOL)].
    FOURNY L; COMBETTE H; STEPHANOPOLI J; SEGAL
    Toulouse Med; 1963 Dec; 64():1238-41. PubMed ID: 14099372
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of chronic psychoses with dipiperon-R 3345.
    NUYTS A
    Acta Neurol Psychiatr Belg; 1963 May; 63():326-32. PubMed ID: 13939279
    [No Abstract]   [Full Text] [Related]  

  • 19. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice.
    López-Muñoz F; Alamo C
    Brain Res Bull; 2009 Apr; 79(2):130-41. PubMed ID: 19186209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A SPECIFIC MEDICATION FOR CHOREIC MOVEMENT, 4'-FLUORO-4-(4-(P-CHLOROPHENYL)-4-HYDROXYPIPERIDINO)-BUTYROPHENONE OR R-1625 (HALOPERIDOL)].
    NICK J; NICOLLE MH
    Bull Mem Soc Med Hop Paris; 1964 Feb 7-14; 115():275-80. PubMed ID: 14136521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.